Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Drug Discovery Informatics Market, by Application
1.4.2 LAMEA Drug Discovery Informatics Market, by Function
1.4.3 LAMEA Drug Discovery Informatics Market, by End User
1.4.4 LAMEA Drug Discovery Informatics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. LAMEA Drug Discovery Informatics Market by Application
5.1 LAMEA Drug Discovery Market by Country
5.2 LAMEA Drug Development Market by Country
Chapter 6. LAMEA Drug Discovery Informatics Market by Function
6.1 LAMEA Sequencing & Target Data Analysis Market by Country
6.2 LAMEA Molecular Modelling Market by Country
6.3 LAMEA Library & Database Preparation Market by Country
6.4 LAMEA Docking Market by Country
6.5 LAMEA Others Market by Country
Chapter 7. LAMEA Drug Discovery Informatics Market by End User
7.1 LAMEA Pharmaceutical Companies Market by Country
7.2 LAMEA Biotechnology Companies Market by Country
7.3 LAMEA Contract Research Organizations Market by Country
7.4 LAMEA Others Market by Country
Chapter 8. LAMEA Drug Discovery Informatics Market by Country
8.1 Brazil Drug Discovery Informatics Market
8.1.1 Brazil Drug Discovery Informatics Market by Application
8.1.2 Brazil Drug Discovery Informatics Market by Function
8.1.3 Brazil Drug Discovery Informatics Market by End User
8.2 Argentina Drug Discovery Informatics Market
8.2.1 Argentina Drug Discovery Informatics Market by Application
8.2.2 Argentina Drug Discovery Informatics Market by Function
8.2.3 Argentina Drug Discovery Informatics Market by End User
8.3 UAE Drug Discovery Informatics Market
8.3.1 UAE Drug Discovery Informatics Market by Application
8.3.2 UAE Drug Discovery Informatics Market by Function
8.3.3 UAE Drug Discovery Informatics Market by End User
8.4 Saudi Arabia Drug Discovery Informatics Market
8.4.1 Saudi Arabia Drug Discovery Informatics Market by Application
8.4.2 Saudi Arabia Drug Discovery Informatics Market by Function
8.4.3 Saudi Arabia Drug Discovery Informatics Market by End User
8.5 South Africa Drug Discovery Informatics Market
8.5.1 South Africa Drug Discovery Informatics Market by Application
8.5.2 South Africa Drug Discovery Informatics Market by Function
8.5.3 South Africa Drug Discovery Informatics Market by End User
8.6 Nigeria Drug Discovery Informatics Market
8.6.1 Nigeria Drug Discovery Informatics Market by Application
8.6.2 Nigeria Drug Discovery Informatics Market by Function
8.6.3 Nigeria Drug Discovery Informatics Market by End User
8.7 Rest of LAMEA Drug Discovery Informatics Market
8.7.1 Rest of LAMEA Drug Discovery Informatics Market by Application
8.7.2 Rest of LAMEA Drug Discovery Informatics Market by Function
8.7.3 Rest of LAMEA Drug Discovery Informatics Market by End User
Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Accenture PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Infosys Limited
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Charles River Laboratories International, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Partnerships, Collaborations, and Agreements:
9.6.4.2 Acquisition and Mergers:
9.6.5 SWOT Analysis
9.7 Agilent Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Illumina, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segment and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Certara, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.9.6 SWOT Analysis
9.10. Jubilant Pharmova Limited
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 SWOT Analysis
Unique Offerings 